← Open Payments lookup

MARK RESTER: Open Payments

NPI 1538140512 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,230 in 40 payments from 14 companies in 2025. Trend: 2023 $1,952 · 2024 $1,334 · 2025 $1,230

Food & beverage: $1,230
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.2$234
ABBVIE INC.13$194
Janssen Pharmaceuticals, Inc4$170
Otsuka America Pharmaceutical, Inc.4$164
Avadel CNS Pharmaceuticals, LLC4$105
Supernus Pharmaceuticals, Inc.1$92
E.R. Squibb & Sons, L.L.C.3$62
Axsome Therapeutics, Inc.2$50
Tris Pharma Inc2$42
JAZZ PHARMACEUTICALS INC.1$36

Products named: FANAPT, VRAYLAR, REXULTI, SPRAVATO, LUMRYZ, Qelbree, COBENFY, Auvelity.

Industry payments across MS — which companies pay providers there.